Long Non-coding RNAs Are Significantly Associated with Prognosis and Response to Therapies in Gastric Cancer
Overview
Overview
Journal
Clin Transl Med
Publisher
Wiley
Specialty
General Medicine
Date
2021 Jun 29
PMID
34185430
Citations
1
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Clinically conserved genomic subtypes of gastric adenocarcinoma.
Jeong Y, Eun Y, Lee S, Kang S, Yim S, Kim E Mol Cancer. 2023; 22(1):147.
PMID: 37674200 PMC: 10481468. DOI: 10.1186/s12943-023-01796-w.
References
1.
Lee J, Chu I, Heo J, Calvisi D, Sun Z, Roskams T
. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology. 2004; 40(3):667-76.
DOI: 10.1002/hep.20375.
View
2.
Pietrantonio F, Miceli R, Raimondi A, Kim Y, Kang W, Langley R
. Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer. J Clin Oncol. 2019; 37(35):3392-3400.
DOI: 10.1200/JCO.19.01124.
View
3.
Sohn B, Hwang J, Jang H, Lee H, Oh S, Shim J
. Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project. Clin Cancer Res. 2017; 23(15):4441-4449.
PMC: 5785562.
DOI: 10.1158/1078-0432.CCR-16-2211.
View
4.
Li X, Zhang C, Gong T, Ni X, Li J, Zhan D
. A time-resolved multi-omic atlas of the developing mouse stomach. Nat Commun. 2018; 9(1):4910.
PMC: 6249217.
DOI: 10.1038/s41467-018-07463-9.
View
5.
Lee J, Kim H, Lee J, Shin S, Oh S, Kwon G
. Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT. Gastroenterology. 2018; 155(3):799-814.e13.
DOI: 10.1053/j.gastro.2018.05.024.
View